Global
Pharmaceuticals

Meet BASF Pharma Solutions @ AAPS PharmSci 360

Date

to
Add to calendar

We're bringing our global expertise to AAPS PharmSci 360

Schedule a meeting with one of our 30+ colleagues from North- and South America, Europe and Asia Pacific. BASF Pharma Solutions is ready to network, discuss your challenges and spark innovation.

Schedule a meeting

From Partner Presentations to Roundtables and Posters, BASF Pharma Solutions has content to meet your needs. See details below on what you can expect to learn from BASF at AAPS PharmSci 360 this year.

PowerPoint-Präsentation

Partner Presentations

Lipid-based Excipients for Skin Drug Permeation by IVPT Studies

October 27th 9-10am EST

Addressing Challenges in Oral Solid Dosage Form Development & Manufacturing
November 5th 9-11am EST

Presentation Abstracts

PowerPoint-Präsentation

Roundtables

Leveraging Digitalization to Solve Coating Formulation Challenges with ZoomLab™ 2.0
October 29th 9-10am EST

The Amorphous Solid Dispersion Ecosystem: Current Challenges and Future Opportunities
October 30th 9-10am EST

Taste Masking as an Alternative to Improve Patient Convenience and Compliance
November 4th 9-10am EST

Full Agenda

video_your-virtual-assistants.jpg

Expanding the toolbox of surfactants available for biologics formulations with Kolliphor® HS 15 and Kolliphor® ELP

Presenter: Bijan Zakeri

The purpose of this study was to evaluate the performance of the surfactants Polyoxyl 15 Hydroxystearate (Kolliphor® HS 15) and Polyoxyl-35-castor oil (Kolliphor® ELP) in stabilizing proteins formulations. Surfactants are an essential component of biologics formulations, as they stabilize protein therapeutics such as monoclonal antibodies and fusion proteins against destabilizing interfacial and hydrophobic interactions. The current toolbox of surfactants used in approved biologics formulations is limited to polysorbate 80, polysorbate 20, and poloxamer 188, with polysorbate 80 being the most commonly used surfactant. However, it is well established that polysorbates suffer from degradation issues that can cause safety concerns and damage to the active pharmaceutical ingredients (APIs). Therefore, there is an unmet need within the biopharmaceutical industry for additional surfactants that can be used to stabilize biologics formulations for parenteral administration.

Taste Masking of Drug Layered Pellets with the Kollicoat® Smartseal 100P

Presenter: Jiantao Zhang

Taste-masking has proven to be a useful technique to improve patient compliance of oral dosages having bitter actives, especially for pediatric and geriatric products. Kollicoat® Smartseal 100P, a spray dried powder of methyl methacrylate-diethylaminoethyl methacrylate copolymer is an excellent coating polymer for taste masking as it is insoluble in saliva (pH 6.8-7.2) and dissolves quickly in the stomach (pH < 5.5). Highly soluble drugs when being coated can generate high osmotic pressure, resulting in a high concentration gradient across the coating layer and accelerating the drug release. This causes challenges for taste masking of water-soluble actives. In this study, the purpose is to evaluate the taste masking effect of Kollicoat® Smartseal 100P by using Diphenhydramine HCl (DPH), a highly water-soluble drug with strong bitter taste the model drug.

Lipid-based Excipients for Skin Drug Permeation by IVPT Studies

Oct. 27th, 9am-10am EST
Presenters: Narasimha Murthy, Norman Richardson
Moderator: Benjamin Goodyear

Previous in vitro studies with model membranes (i.e. Strat-M®), porcine skin and human skin suggest that cocoyl caprylocaprate, isopropyl myristate and octyldodecanol might be able to enhance the penetration of some common topical drugs, spanning a wide range of Log P values . To validate these observations, in vitro permeation studies through human skin were conducted with topical semi-solid creams containing cocoyl caprylocaprate (Kollicream® 3C), isopropyl myristate (Kollicream® IPM), octyldodecanol (Kollicream® OD), and/ or mineral oil. Each of these excipients was formulated into common cream bases which contained three different topical analgesic drugs, Ketoprofen (Log P = 3.1), Ibuprofen (Log P = 3.97) or Diclofenac Sodium (Log P = 04.51). Critical Quality Attributes (CQAs) such as pH, emulsion globule size, API partitioning, etc. were measured for all of the creams. This presentation will report the effect of the different lipid-based excipients (and mineral oil) on the skin permeation of each of the three APIs and compare with the CQAs to better understand their mechanism of penetration enhancement. 

Addressing Challenges in Oral Solid Dosage Form Development & Manufacturing

Nov. 5th 9am – 11am EST
Presenters: Ferdinand Brandl, Thorsten Cech, Krizia Karry, Suresh Bandari
Moderator: Sandip Tiwari

Development of oral solid dosage forms presents numerous challenges to formulators. These range from development studies to achieve startup formulation, speed and simplicity in process design, scale-up, and cost considerations. In this session we will present a digital tool for predicting a startup formulation along with recommendations for optimal drug-excipient combinations. Approaches to taste masking solutions in oral solid dosage forms using novel film forming polymer will be discussed. Challenges and opportunities in the development of oral controlled release formulations using hot melt extrusion 3D printing technology will also be discussed. Contributions from both Industry and Academia will be structured in four targeted presentations followed by Q&A sessions.

Ready to meet with a BASF expert? Fill in the form below to reserve time to meet with our representatives. For your convenience, we have availabilities across all time zones! 

This field is required.

* required

An error occurred while submitting this form. Error Code: